期刊文献+

泛素样蛋白-蛋白酶体系统与结核分枝杆菌致病性的相关性研究进展 被引量:2

Research progress about the relationship between the pup-proteasome system and the pathogenicity of Mycobacterium tuberculosis
下载PDF
导出
摘要 结核分枝杆菌(Mycobacterium Tuberculosis,MTB)中的泛素样蛋白-蛋白酶体系统(prokaryotic ubiquitin-like protein-proteasome system,PPS),主要介导和调控MTB体内蛋白质的降解。在特定环境下,MTB中泛素样蛋白(prokaryotic ubiquitin-like protein,Pup)选择性标记特定的蛋白质,并在辅助因子的帮助下将靶蛋白送入蛋白酶体内降解,对MTB在宿主体内的生长、繁殖及致病性发挥重要调控作用。本文首先简单介绍了MTB中Pup、蛋白酶体的结构特点、作用及PPS降解靶蛋白的主要过程,接着重点介绍了PPS对MTB致病性的调控机制,及如何通过改变PPS作用来降低MTB致病性等一些最新进展,希望能够为寻找新型抗结核药物提供方向。 The pup-proteasome system of Mycobacterium tuberculosis is the most basic and important control system which could induce changes in the external environment, and make the corresponding reaction. In a particular context, prokary- otic ubiquitin-like protein in Mycobacterium tuberculosis marks the specific proteins selectively. It sends the target protein into proteasome with the help of cofactors, and playing an important role in growth, multiplication and pathogenicity in host body. In this article, we first introduce structural characteristics and function of the prokaryotic ubiquitin-like protein and protea- some, and the main proceses of the prokaryotic ubiquitin-like protein-proteasome system target protein degradation. Then we mainly introduce some of the latest progress, such as the regulatory mechanism of PPS for MTB pathogenic, and how to reduce the MTB pathogenic role by changing the PPS, etc. , providing direction for looking for new anti-tuberculosis drugs.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2014年第9期971-974,977,共5页 Chinese Journal of Zoonoses
基金 国家自然科学基金项目(No.81260261 81160192 30960355) 新疆生产建设兵团医药专项资金项目(No.2012BA022) 石河子大学科学技术研究发展计划"自然科学与计划创新"重点项目(No.ZRKX2010ZD01)~~
关键词 结核分枝杆菌 泛素样蛋白-蛋白酶体系统 蛋白酶体 致病性 Mycobacterium tuberculosis prokaryotic ubiquitin-like protein proteasome pathogenicity
  • 相关文献

参考文献1

二级参考文献15

  • 1周永列,吕亚萍,许武林,胡惟孝.连续荧光监测法测定蛋白酶体活性及其在筛选蛋白酶体抑制剂中的应用[J].中国临床药理学与治疗学,2008,13(10):1127-1133. 被引量:4
  • 2米毅,张建新,李英,楼丽广.蛋白酶体抑制剂筛选模型的建立[J].中国药理学通报,2005,21(1):123-124. 被引量:1
  • 3Cerda-Maira F, Darwin KH. The Mycobacterium tuberculosis proteasome: more than just a barrel-shaped protease. Microbes Infect, 2009, 11(14-15): 1150-1155.
  • 4Lin G, Li D, de Carvalho LP, et al. Inhibitors selective for mycobacterial versus human proteasomes. Nature, 2009, 461: 621-626.
  • 5Vandal OH, Nathan CF, Ehrt S. Acid resistance in Myeobacterium tuberculosis. J Bacteriol, 2009, 191 : 47144721.
  • 6Darwin KH, Ehrt S, Gutien'ez-Ramos JC, et al. The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide. Science, 2003, 302: 1963-1966.
  • 7Ng VH, Cox JS, Sousa AO, et al. Role of KaIG eatalase- peroxidase in mycobacterlal pathogenesis : countering the phagocyte oxidative burst. Mol Microbiol, 2004, 52: 1291-1302.
  • 8Lightcap ES, McCormack TA, Pien CS, et al. Proteasome inhibition measurements: clinical application. Clin Chem, 2000, 46: 673-683.
  • 9Nam S, Smith DM, Dou QP. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem, 2001,276: 13322-13330.
  • 10Wilson HL, Aldrich HC, Maupin-Furlow J. Halophilic 20S proteasomes of the archaeon Haloferax volcanii: purification, characterization, and gene sequence analysis. J Bacteriol, 1999, 181 : 5814-5824.

同被引文献17

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部